Receive cutting-edge information from some of the foremost cancer authorities from the University of Pennsylvania, delivered to your email.
Sonidegib is a hedgehog pathway inhibitor used to treat locally advanced basal cell cancers.
Lenvatininb (Lenvima) is a VEGF tyrosine kinase inhibitor used in the treatment of locally recurrent or metastatic, progressive, radioactive iodine-refractory differentiated thyroid cancer (DTC).
Dinutuximab (Unituxin ™) is an intravenous monoclonal antibody for treatment of neuroblastoma.
Are you concerned about your risk of developing cancer?
What’s My Risk? Is a program designed to help you learn about the factors that increase your cancer risk – and most importantly, what you can do to decrease that risk.
Aug 28, 2015
Negative independent prognostic factor for disease-specific survival and disease-free interval
Aug 28, 2015
In study of those under 50 with invasive form of disease, 12 percent had BRCA1, BRCA2 mutations
Aug 29, 2015
Associated with polypharmacy, vision impairment, and urologic comorbidities
Aug 27, 2015
ERCC1 C118T genotype may identify good prognosis in subgroup of pEBV-negative patients
Our award winning cancer education content is now available for licensing and syndication.
Please help us to better understand skin cream usage for patients who develop skin redness/irritation during radiation therapy. We are very interested in the opinions and experience of both patients and providers regarding skin cream usage for radiation-related skin reactions. Your participation in this survey would be much appreciated.